Blood-clotting wound dressings are limited by their need for refrigeration and short shelf life: their component proteins tend to break down. Egea Biosciences in San Diego is developing (under Army contract) a compression bandage-the type used for major wounds-coated with a blood-clotting substance that might avoid those limitations.
The dressing is a variant of the fibrinogen that the body produces to promote clotting. A key ingredient is a protein found in spider silk, says Egea CEO Glen A. Evans. This protein could form clots for large wounds that otherwise would continue to bleed. The synthetic powder does not degrade over time or need refrigeration. It is several years from commercial introduction.
A Roomba recorded a woman on the toilet. How did screenshots end up on Facebook?
Robot vacuum companies say your images are safe, but a sprawling global supply chain for data from our devices creates risk.
A startup says it’s begun releasing particles into the atmosphere, in an effort to tweak the climate
Make Sunsets is already attempting to earn revenue for geoengineering, a move likely to provoke widespread criticism.
10 Breakthrough Technologies 2023
These exclusive satellite images show that Saudi Arabia’s sci-fi megacity is well underway
Weirdly, any recent work on The Line doesn’t show up on Google Maps. But we got the images anyway.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.